Karyopharm Therapeutics (KPTI) EPS (Basic) (QoQ) (2013 - 2025)
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) EPS (Basic) (QoQ) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 640.79 Bn | 620.03 Bn | 17.26 Bn |
| 2 | AbbVie | 445.95 Bn | 439.38 Bn | 12.70 Bn |
| 3 | Merck | 357.40 Bn | 350.26 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.40 Bn | 259.71 Bn | 11.24 Bn |
| 5 | Pfizer | 156.52 Bn | 144.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.15 Bn | 44.77 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.02 Bn | 43.02 Bn | - |
| 8 | Incyte | 24.59 Bn | 20.06 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.31 Bn | 18.64 Bn | 683.80 Mn |
| 10 | Karyopharm Therapeutics | 46.59 Mn | -18.51 Mn | 32.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -45.97% |
| Sep 30, 2025 | 11.58% |
| Jun 30, 2025 | -56.01% |
| Mar 31, 2025 | 27.07% |
| Dec 31, 2024 | 1.29% |
| Sep 30, 2024 | -230.51% |
| Jun 30, 2024 | 160.75% |
| Mar 31, 2024 | 12.17% |
| Dec 31, 2023 | -22.15% |
| Sep 30, 2023 | -5.57% |
| Jun 30, 2023 | 4.99% |
| Mar 31, 2023 | 37.56% |
| Dec 31, 2022 | -6.35% |
| Sep 30, 2022 | 26.48% |
| Jun 30, 2022 | -15.41% |
| Mar 31, 2022 | -203.76% |
| Dec 31, 2021 | 174.91% |
| Sep 30, 2021 | 3.65% |
| Jun 30, 2021 | 7.51% |
| Mar 31, 2021 | -27.84% |